Bekaii-Saab, T. S., Cosgrove, D., Sruti, I., Shi, J., Dai, W., Patton, G. A., Appukkuttan, S., Hocum, B. T., Katta, A., Earl, J., Babajanyan, S., Barzi, A. (2025). Real-world (RW) treatment patterns and clinical outcomes of patients treated with sequential regorafenib and trifluridine/tipiracil ± bevacizumab (BEV) for metastatic colorectal cancer (mCRC) in the United States (US) community oncology setting: The SEQRT2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.62